CUMULASE— 510(k) K042495

Substantially Equivalent

Halozyme Therapeutics, Inc.

FDA 510(k) clearance K042495 for CUMULASE, Substantially Equivalent on 2005-04-14. Applicant: Halozyme Therapeutics, Inc..

Clearance details

Applicant: Halozyme Therapeutics, Inc.
Product code: Code MQL
Advisory panel: Obstetrics/Gynecology
Date received: 2004-09-14
Decision date: 2005-04-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.